Until now, targeted drug delivery using magnetic nanoparticles and an external magnet has only been possible under static positioning of the magnet. In this configuration, the external magnet cannot be moved during the application, which precludes individual and precise targeting of complex regions of interest.
To circumvent this limitation, SEON achieved its next milestone on the road to clinical translation in 2019 - the installation of a robot-controlled electromagnet. Although the robot weighs two tons, it is able to perform its movements more precisely than a human hand. In the future, this robot-controlled magnet, which can be freely programmed and positioned, will be able to approach all regions of the body, and will also be able to dynamically change its position during treatment.
But the progress should not stop at that. In the future, the application of artificial intelligence (AI) will make the individual treatment of patients even more effective. The vision: based on AI-supported interpretation of image data of the target region, for example an angiographic image of a tumor, it should be possible to achieve an automated, reproducible and personalized positioning of the magnet in the disease-affected body region of the patient. with the help of the robot.
The world's first magnetic robot : revolutionary technology at the Universitätsklinikum Erlangen
Erster Magnetroboter weltweit: Revolutionäre Technik an der Uniklinik Erlangen
Kurzbericht im Bayerischen Fernsehen
Sendetermin: 17.09.2019 um 17:30 Uhr
Forschungsstiftung Medizin at the Universitätsklinikum Erlangen
IBAN: DE 69 76350000 0000062000
Nanomedizin Prof. Alexiou